The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Aging Neurosci.
Sec. Alzheimer's Disease and Related Dementias
Volume 16 - 2024 |
doi: 10.3389/fnagi.2024.1477047
This article is part of the Research Topic Genetic Underpinnings of Alzheimer's and Parkinson's: Insights and Innovations View all articles
Preliminary reference values for Alzheimer's disease plasma biomarkers in Congolese individuals with and without dementia
Provisionally accepted- 1 Department of Rehabilitation Medicine, Emory University, Atlanta, United States
- 2 University of Kinshasa and Catholic University of Congo, School of Medicine, Kinshasa, Democratic Republic of Congo
- 3 Emory University, Atlanta, United States
- 4 Department of Psychology, Mercer University, Atlanta, Georgia, United States
- 5 Department of Biomedical Informatics, Emory University, Atlanta, Georgia, United States
- 6 Department of Neurology, University of Kinshasa, Kinshasa, Kinshasa, Democratic Republic of Congo
- 7 Memory Clinic of Kinshasa, Kinshasa, Democratic Republic of Congo
- 8 Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, Netherlands
- 9 Memory and Aging Center, Medical Center, University of California, San Francisco, San Francisco, California, United States
- 10 ALZpath, Inc, San Francisco, United States
- 11 Bloomberg School of Public Health, Department of Epidemiology, Johns Hopkins Medicine, Johns Hopkins University, Baltimore, Maryland, United States
- 12 Rollins School of Public Health, Department of Epidemiology, Emory University, Atlanta, United States
Background: Western countries have provided reference values (RV) for Alzheimer's disease (AD) plasma biomarkers, but there are not available in Sub-Saharan African populations.Objective: We provide preliminary RV for AD and other plasma biomarkers including amyloid-β (Aβ42/40), phosphorylated tau-181 and 217 (p-tau181, p-tau217), neurofilament light (Nfl), glial fibrillary acidic protein (GFAP), interleukin 1b and 10 (IL-1b and IL-10) and tumor necrosis factor α (TNFα) in Congolese adults with and without dementia.Methods: 85 adults (40 healthy and 45 dementia) over 50 years old were included. Blood samples were provided for plasma AD biomarkers Aβ42/40 and p-tau181, p-tau217; Nfl and GFAP; IL-1b and IL-10 and TNFα analyzed using SIMOA. Linear and logistic regressions were conducted to evaluate differences in biomarkers by age and gender and neurological status, and for the prediction of dementia status by each individual biomarker. RV were those that optimized sensitivity and specificity based on Youden's index.In this sample of 85 adults, 45 (53%) had dementia, 38 (45%) were male, overall mean age was 73.2 (SD 7.6) years with 8.3 (5.4) years of education. There were no significant differences in age, gender, and education based on neurological status. Biomarker concentrations did not significantly differ by age except for p-tau181 and GFAP and did not differ by sex. Preliminary normal value cutoffs of various plasma in pg/ml were 0.061 for Aβ42/40, 4.50 for p-tau 181, 0.008 for p-tau 217, 36.5 for Nfl, 176 for GFAP, 1.16 for TNFa, 0.011 for IL-1b, and 0.38 for IL-10. All AUCs ranged between 0.64-0.74. P-tau 217 [0.72 (95% CI: 0.59, 0.84)] followed by GFAP [0.72 (95% CI: 0.61, 0.83)], and Nfl [0.73 (95% CI: 0.62, 0.84)] had the highest AUC compared to other plasma biomarkers.This study provides RV which could be of preliminary utility to facilitate the screening, clinical diagnostic adjudication, and classification, and prognosis of dementia in Congolese adults.
Keywords: Alzheimer's disease, Reference Values, biomarkers, Congo, Dementia
Received: 06 Aug 2024; Accepted: 28 Oct 2024.
Copyright: © 2024 Ikanga, Jean, Medina, Patel, Schwinne, Epenge, Gikelekele, Tshengele, Kavugho, Mampunza, Mananga, Teunissen, Stringer, Rojas, Chan, Lario Lago, Kramer, Boxer, Jeromin, Gross and Alonso. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jean Ikanga, Department of Rehabilitation Medicine, Emory University, Atlanta, United States
Saranya S. Patel, Emory University, Atlanta, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.